Diğer Nadir Görülen Nörokütanöz Hastalıklar
Özet
Nörokutanöz hastalıklar, deri ve sinir sistemi başta olmak üzere çoklu organ tutulumu ile seyreden, genellikle genetik kökenli nadir klinik tabloları kapsar. Gorlin-Goltz, Parry-Romberg, Lipoid proteinoz ve Proteus sendromu gibi örnekler, farklı genetik mutasyonlara bağlı olarak gelişen ve multidisipliner takip gerektiren bu hastalık grubunun önemli temsilcileridir. Tanı, klinik kriterlerin belirlenmesi ve sistemik anomalilerin detaylı değerlendirilmesiyle konulurken, tedavi genellikle semptomların hafifletilmesine ve olası komplikasyonların yönetimine odaklanır. Erken teşhis, hastaların yaşam kalitesini artırmak ve komplikasyonları yönetmek adına büyük önem taşımaktadır.
Neurocutaneous diseases encompass a group of rare, typically genetic disorders characterized by involvement of the skin and the nervous system, along with potential multi-organ system manifestations. Clinical entities such as Gorlin-Goltz syndrome, Parry-Romberg syndrome, lipoid proteinosis, and Proteus syndrome illustrate the complexity of these conditions, which often require a multidisciplinary approach for effective management. Diagnosis relies on established clinical criteria and a comprehensive assessment of systemic anomalies, while therapeutic strategies generally focus on alleviating symptoms and managing secondary complications. Early detection is crucial for improving patient outcomes and mitigating the long-term impact of these diseases.
Referanslar
Al-Jarboua MN, Al-Husayni AH, Al-Mgran M, Al-Omar AF. Gorlin-Goltz Syndrome: A Case Report and Literature Review. Cureus. 2019;11(1):e3849.
Gorlin R, Goltz R. Multiple nevoid bazal- cell epitellioma, jaw cysts and bifid rib. A syndrome. N Engle J Med. 1960;5:908-12.
Casaroto AR, Loures DC, Moreschi E, Veltrini VC, Trento CL, Gottardo VD, Lara VS. Early diagnosis of Gorlin-Goltz syndrome: case report. Head Face Med. 2011;7:2.
Spiker AM, Troxell T, Ramsey ML. Gorlin Syndrome.: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.
Bressler SC, Padwa BL, Granter SR Nevoid Bazal Cell Carsinoma Syndrome (Gorlin Syndrome). Head and Neck Pathol. 2016;10:119-24.
Bree AF, Shah MR for the BCNS Colloquium Group. Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). Am J Med Genet Part A. 2011;155:2091-7.
Oikarinen VJ. Keratocyst recurrences at intervals of more than 10 years: case reports. Br J Oral Maxillofac Surg. 1990;28:47-9.
Panagiatakaki E and Arzimanoglou A. Aicardi’s Diseases of the Nervous System in Childhood 4th Edition. Riverside Publishing Solutions Ltd. London: 2018. p. 205-240.
Arif T, Fatima R, Sami M. Parry-Romberg syndrome: a mini review. Acta Dermatovenerol Alp Pannonica Adriat. 2020;29(4):193-9.
Jun JH, Kim HY, Jung HJ, Lee WJ, Lee SJ, Kim DW, et al. Parry–Romberg syndrome with en coup de sabre. Ann Dermatol. 2011;23:342-7.
Kumar AA, Kumar RA, Shantha GPS, Aloogopinathan G. Progressive hemi facial atrophy—Parry Romberg syndrome presenting as severe facial pain in a young man: a case report. Cases J. 2009;2:6776.
Appenzeller O, Stevens JM, Kruszynski R, Walker S. Neurology in ancient faces. J Neurol Neurosurg Psychiatry. 2001;70:524-9.
Kumar NG, Maurya BS, Sudeep CS. Parry Romberg Syndrome: Literature Review and Report of Three Cases. J Maxillofac Oral Surg. 2019;18(2):210-6.
Miller MT, Sloane H, Goldberg MF, Grisolano J, Frenkel M, Mafee MF. Progressive hemifacial atrophy (Parry–Romberg disease). J Pediatr Ophthalmol Strabismus. 1987;24:27-36.
Sathornsumetee S, Schanberg L, Rabinovich E, Lewis Jr D, Weisleder P. Parry– Romberg syndrome with fatal brain stem involvement. J Pediatr. 2005;146:429-31.
Holland KE, Steffes B, Nocton JJ, Schwabe MJ, Jacobson RD, Drolet BA. Linear scleroderma en coup de sabre with associated neurological abnormalities. Pediatrics. 2006;117:e132–6.
Bellusci C, Liguori R, Pazzaglia A, Badiali L, Schiavi C, Campos EC. Bilateral Parry–Romberg syndrome associated with retinal vasculitis. Eur J Ophthalmol. 2003;13:803-6.
Miller MT, Spencer MA. Progressive hemifacial atrophy. A natural history study. Trans Am Ophthalmol Soc. 1995;93:203-15.
Balan P, Gogineni SB, Shetty SR, D’Souza D. Three-dimensional imaging of progressive facial hemiatrophy (Parry–Romberg syndrome) with unusual conjunctival findings. Imaging Sci Dent. 2011;41:183-7.
Szcepanska I, Wilczynska M, Kakolewska-Maczynska J. Facial asymmetry, changes in the masticatory organ and evaluation of thickness of soft tissues by the ultrasonic method in cases of secondary facial hemiatrophy following scleroderma. Czas Stomatol. 1974;27:375-84.
Tolkachjov SN, Patel NG, Tollefson MM. Progressive hemi facial atrophy: a review. Orphanet J Rare Dis. 2015;10:39.
Yu-Feng L, Lai G, Zhi-Yong Z. Combined treatments of facial contour deformities resulting from Parry–Romberg syndrome. J Reconstr Microsurg. 2008;24:333-42.
Bekiesińska-Figatowska M, Sawicka E, Żak K, Szczygielski O. Age related changes in brain MR appearance in the course of neurocutaneous melanosis. Eur J Radiol. 2016;85(8):1427-31.
Levy R, Lara-Corrales I. Melanocytic Nevi in Children: A Review. Pediatr Ann. 2016;45(8):e293-8.
Vanood A, Lee YA, Leleszi E, Krishnan A. Symptomatic neurocutaneous melanosis: mild clinical onset in a teenager. BMJ Case Rep. 2020;13(11):e235772.
Katzenellenbogen I, Ungar H. Lipoid proteinosis; reinvestigation of a case previously reported by Urbach and Wiethe in 1929. Dermatologica. 1957;115(1):23-35.
Chan I, Liu L, Hamada T, Sethuraman G, McGrath JA. The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1. Exp Dermatol. 2007;16(11):881-90.
Di Giandomenico S, Masi R, Cassandrini D, El-Hachem M, De Vito R, Bruno C, Santorelli FM. Lipoid proteinosis: case report and review of the literature. Acta Otorhinolaryngol Ital. 2006;26(3):162-7.
LeWitt TM, Paller AS, Bell A, Zhou X. Lipoid Proteinosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.
Singh S, Mittal S, Bhari A,2 Bhari N. Lipoid proteinosis BMJ Case Rep. 2017; 2017
Osler-Weber-Rendu Disease. Macri A, Wilson AM, Shafaat O, Sharma S. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.
Moody MN, Landau JM, Goldberg LH. Nevus sebaceous revisited. Pediatr Dermatol. 2012;29(1):15-23.
Haberland C, Perou M. Encephalocraniocutaneous lipomatosis. A new example of ectomesodermal dysgenesis. Arch Neurol. 1970;22:144-55.
Fishman MA, Chang CS, Miller JE. Encephalocraniocutaneous lipomatosis. Pediatrics. 1978;61:580-2.
Hunter AG. Oculocerebrocutaneus and Ensefalokraniokutanöz lipomatosis syndromes: Blind men and elephant or seperate syndromes? Am J Med Genet A 2006;140:709-726
Moog U. Encephalocraniocutaneous lipomatosis. J Med Genet. 2009;46:721-729.
Nowaczyk MJ, Mernagh JR, Bourgeois JM, et al. Antenatal and postnatal findings in encephalocraniocutaneous lipomatosis. Am J Med Genet. 2000;91:261-6.
Karaman ZF, Özüdoğru ŞE. Encephalocraniocutaneous lipomatosıs (Haberland syndrome) in a newborn baby: a case report with review of literature. Childs Nerv Syst. 2021 Mar 1. doi: 10.1007/s00381-021-05099-7.
Siddiqui S, Naaz S, Ahmad M, Khan ZA, Wahab S, Rashid BA. Encephalocraniocutaneous lipomatosis: a case report with review of literature. Neuroradiol J. 2017;30:578-2.
Kocak O, Yarar C, Carman KB. Encephalocraniocutaneous lipomatosis, a rare neurocutaneous disorder: report of additional three cases. Childs Nerv Syst. 2016;32:559-62.
Moog U, Dobyns WB. An update on oculocerebrocutaneous (Delleman-Oorthuys) syndrome. Am J Med Genet C Semin Med Genet. 2018;178(4):414-22.
Biesecker LG, Sapp JC. Proteus Syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington. Seattle; 2012. p. 1993-2021.
Garrod AE Peculiar pigmentation of the skin of an infant. Trans Clin Soc Lond. 1906;39:216.
Bloch B Eigentumliche bischer nicht beschriebene pigmentaffektion (incontinentia pigmenti). Schweiz Med Wochenschr. 1926;7:404-5.
Berlin AE, Paller AS, Chan LS. Incontinenetia pigmenti: a review and update on the molecular basis of pathophysiology.J Am Acad Derrnatol. 2002;47:169-87.
Kouzak SS, Mendes MS, Costa IM. Cutaneous mosaicisms: concepts, patterns and classifications. An Bras Dermatol. 2013;88(4):507-17.
Chamli A, Litaiem N. Hypomelanosis of Ito. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.
Bodemer C. Incontinentia pigmenti and hypomelanosis of Ito. Handb Clin Neurol. 2013;111:341-7.
Barbel P, Brown S, Peterson K. Identification of Hypomelanosis of Ito in Pediatric Primary Care. J Pediatr Health Care. 2015;29(6):551-4.
Ruiz-Maldonado R, Toussaint S, Tamayo L, Laterza A, del Castillo V. Hypomelanosis of Ito: diagnostic criteria and report of 41 cases. Pediatr Dermatol. 1992 Mar;9(1):1-10
Bindu PS. Sjogren-Larsson Syndrome: Mechanisms and Management. Appl Clin Genet. 2020;13:13-24.
Kousseff BG, Matsuoka LY, Stenn KS, Hobbins JC, Mahoney MJ, Hashimoto K. Prenatal diagnosis of Sjogren-Larsson syndrome. J Pediatr. 1982;101(6):998-1001.
Fuijkschot J, Theelen T, Seyger MM, et al. Sjogren-Larsson syndrome in clinical practice. J Inherit Metab Dis. 2012;35(6):955-62.
Rizzo WB. Genetics and prospective therapeutic targets for Sjogren-Larsson Syndrome. Expert Opinion Orphan Drugs. 2016;4 (4):395–406.
Price VH. Strukturanomalien des Haarschaftes. In: Orfanos CE, editor. Haar und Haarkrankheiten. Stuttgart: Gustav Fischer Verlag; 1979. p. 387-446.
Price VH, Odom RB, Ward WH, Jones FT. Trichothiodystrophy: sulfur-deficient brittle hair as a marker for a neuroectodermal symptom complex. Arch Dermatol. 1980;116:1375-84.
Faghri S, Tamura D, Kraemer KH, DiGiovanna JJ. Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J Med Genet. 2008;45:609-21.
Shareef S, Horowitz D, Kaliyadan F. Cutis Verticis Gyrata. 2020 Aug 25. In: StatPearls [Internet]. Treasure Island Cerebello-trigeminal-dermal dysplasia (FL): StatPearls Publishing; 2021.
Harish V, Clarke F. Isolated cutis verticis gyrata of the glabella and nasal bridge: a case report and review of the literature. J Plast Reconstr Aesthet Surg. 2013;66(10):1421-3.
Zhao D. Li J. Wang K. et al. Treating cutis verticis gyrata using skin expansion method. Cell Biochem Biophys. 2012;62:373-6.
Lamelas AM, Taub PJ, Silver L, Kressel A. Congenital Primary Essential Cutis Verticis Gyrata. Eplasty. 2016;16:ic13.
Radwanski HN, Almeida MW, Pitanguy I. Primary essential cutis verticis gyrata--a case report. J Plast Reconstr Aesthet Surg. 2009;62(11):e430-3.
Gomez MR. Cerebellotrigeminal and focal dermal dysplasia: a newly recognized neurocutaneous syndrome. Brain Dev. 1979;4:253-6.
López-Hernández A. Craniosynostosis, ataxia, trigeminal anaesthesia and parietal alopecia with pons-vermis fusion. 1982;13(2):99-102.
Schell-Apacik CC, Cohen M, Vojta S, Ertl-Wagner B, Klopocki E, Heinrich U, von Voss H. Gomez-Lopez-Hernandez syndrome (cerebello-trigeminal-dermal dysplasia): description of an additional case and review of the literature. Eur J Pediatr. 2008;167(1):123-6.
